Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/ROIV

ROIV

Roivant Sciences Ltd.

Healthcare - GB - listed in USD

Roivant Sciences Ltd. Roivant Sciences Ltd. (ROIV) is a biopharmaceutical company that accelerates the discovery, development, and commercialization of transformative medicines and technologies by creating nimble, autonomous subsidiaries kn…

HQ: London, GL, United Kingdomroivant.com

USD40.82-0.29%vs prev. close

Market snapshot

Price

USD40.82

Daily move

-0.29%

P/E

—

EPS TTM

-0.47

Dividend yield

—

Beta

1.12

Market cap

29.5B

Price history

ROIV price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Roivant Sciences	ROIV	Biotechnology	29.5	—	—	+16.9%	+12.9%	+35.9%	+45.5%	+183.3%	+88.1%

Subscribe to Equity Analytics to compare ROIV with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.